Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
27.53 EUR | -0.22% | +0.79% | -18.05% |
Apr. 29 | J&J, Bristol Myers lose challenges to US drug price negotiation program | RE |
Apr. 29 | Bayer: positive results with Eylea in ophthalmology | CF |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.05% | 29.04B | |
+26.47% | 664B | |
+25.51% | 567B | |
-6.33% | 354B | |
+19.35% | 330B | |
+4.23% | 286B | |
+13.35% | 234B | |
+4.64% | 199B | |
-10.22% | 196B | |
-4.04% | 148B |
- Stock Market
- Equities
- BAYN Stock
- News Bayer AG
- Transcript : Bayer Aktiengesellschaft - Shareholder/Analyst Call